Solésence To Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 31, 2026
Rhea-AI Summary
Solésence (Nasdaq: SLSN) will report fourth quarter and full year 2025 results before the market opens on Tuesday, March 31, 2026, and will host a conference call and webcast the same day.
The call begins at 7:30 a.m. CT / 8:30 a.m. ET with CEO Kevin Cureton and CFO Laura Riffner. Registration and webcast links are provided for dial-in and replay access.
Positive
- None.
Negative
- None.
News Market Reaction – SLSN
In the Mar 20 session, SLSN gained 2.31%, reflecting a moderate positive market reaction. Argus tracked a peak move of +11.2% during that session. Argus tracked a trough of -8.0% from its starting point during tracking. Our momentum scanner triggered 6 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 26 | Leadership appointment | Positive | -1.5% | Named a new Vice President of Brand Partnerships to expand turnkey solutions. |
| Nov 11 | Q3 2025 earnings | Negative | -24.2% | Reported lower revenue, margin compression, and a swing from profit to net loss. |
| Nov 10 | Leadership appointment | Positive | -4.4% | Appointed VP of Innovation and Product Integrity to unify R&D and quality. |
| Oct 30 | Earnings call notice | Neutral | -6.5% | Announced timing and access details for the Q3 2025 earnings conference call. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent history shows negative price reactions around leadership updates and earnings: executive appointments saw modest declines, while weaker Q3 2025 results led to a larger selloff. Even a prior earnings-date announcement coincided with a notable drop.
Over the past several months, Solésence has focused on leadership changes and financial updates. Executive appointments in November 2025 and February 2026 were framed as strengthening innovation and brand partnerships but were followed by modest single‑digit declines. The Q3 2025 earnings release on Nov 11, 2025 highlighted revenue and margin pressure and saw a sharper -24.2% reaction. An earlier notice of an earnings conference call on Oct 30, 2025 also preceded a -6.55% move, setting context for today’s new earnings date announcement.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ROMEOVILLE, Ill., March 19, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the fourth quarter and full year 2025 before the market opens on Tuesday, March 31, 2026, and host a conference call and webcast on the same date.
Fourth Quarter 2025 Conference Call Details
Date / Time: Tuesday, March 31, 2026 – 7:30 a.m. CT, 8:30 a.m. ET
Speakers: Kevin Cureton, President & CEO and Laura Riffner, Chief Financial Officer
Webcast Link: https://edge.media-server.com/mmc/p/btv3gq6b
Dial-In Link: https://register-conf.media-server.com/register/BI2103cfa8634b4409927981d42999af41
To receive the dial-in number, as well as your personalized PIN, you must register at the above link. Once registered, you will also have the option to have the system dial-out to you once the conference call begins. If you forget your PIN prior to the conference call, you can simply re-register.
The call may also be accessed through the Company’s investor relations website, at https://ir.solesence.com/. Please join the conference call at least five minutes before the start time.
About Solésence, Inc.
Solésence, Inc. (Nasdaq: SLSN) is a leader in scientifically-driven health care solutions across beauty and life science categories. With a mission to deliver joy through innovation, inclusivity and the science of beautiful skin, we have redefined mineral-based sun protection by maximizing transparency, effectiveness, aesthetics, and wearability — empowering individuals to embrace beauty on their own terms. Combining best-in-class skin health solutions with the celebration of self-care, we allow brands to deliver unique product claims and attributes by seamlessly integrating protection, prevention, and treatment technologies into daily use products. Learn more at solesence.com.
Media Contact:
Investor Relations Contact:
